NEWS MAKER @NEWS_MAKER
A key monoclonal antibody used to treat people with weak immune systems who catch Covid is no longer authorized for use in the U.S. because it is not effective against emerging omicron subvariants. https://t.co/Uu1UezAk1b — PolitiTweet.org